Waterhouse Brands, LLC, a life sciences brand reputation agency, announced the appointment of Tom Haan as Chief Brand Strategist and the integration of his firm, 22 Fillmore, into Waterhouse. The combination deepens the agency's expertise in corporate positioning, brand identity design and digital development, according to the announcement from Waterhouse Brands.
Haan assumes the Chief Brand Strategist role from Founder and CEO Kim Kraemer, who has held both positions since founding Waterhouse in 2017. The handoff adds senior leadership as Waterhouse enters its tenth year, a transition that matters for a firm whose clients rely on brand work during high-stakes corporate moments. For readers in the life sciences sector, the move signals that Waterhouse is building bench strength in strategy and design rather than treating them as secondary services.
The integration expands Waterhouse's capabilities in corporate positioning, brand identity design, digital development, brand strategy and integrated communications. Those capabilities are aimed at life sciences clients navigating launches, pivots, initial public offerings or mergers and acquisitions, and commercialization. Because those events often determine whether a young biotech can attract partners, investors and talent, the depth of a brand agency's strategic and digital bench can shape how credibly a company tells its story at exactly the moment scrutiny peaks.
Waterhouse describes itself as an award-winning life sciences brand reputation agency integrating market positioning, branding, public relations and strategic communications. Founded in 2017, the agency says it helps companies navigate pivotal moments, from emerging from stealth and preparing for an IPO to strategic transformation and commercialization. Its proprietary ALIGN methodology connects vision, culture and image to build reputation from the inside out, and the firm brings together strategic counsel, brand identity, digital experiences and communications programs intended to help clients differentiate their businesses, engage stakeholders and earn trust.
The agency maintains teams in the San Francisco Bay Area, San Diego, and Boston, serving life sciences companies advancing innovations that improve human health. That geographic footprint places Waterhouse in three major U.S. biotech clusters, where competition for attention among emerging companies is intense. The full announcement, including downloadable images and bios, is available through a click here link provided by the company.
The practical implication for the industry is consolidation of brand and digital expertise under one roof at a time when life sciences firms are expected to communicate with investors and patients across more channels than ever. Bringing 22 Fillmore's operations inside Waterhouse suggests the agency intends to compete for mandates that span positioning, identity and digital build-out rather than discrete projects. For clients weighing agency partners ahead of a launch, financing or exit, the combined offering may reduce the number of vendors involved in crafting and delivering a corporate narrative.


